Pitolisant: all 31 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- A Study of Pitolisant in Participants With Prader-Willi SyndromeEnrolling by invitationNCT07219485Phase 3
- A Study of Pitolisant in Patients With Prader-Willi SyndromeRecruitingNCT06366464Phase 3
- Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1CompletedNCT04886518Phase 2Results posted
- Pitolisant Effects on Alcohol Self-Administration in Heavy DrinkersTerminatedNCT04596267Phase 1Results posted
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label ExtensionCompletedNCT04257929Phase 2Results posted
- Insulin Tolerance Test Study in Patients With Type 1 DiabetesTerminatedNCT04026750Phase 1Results posted
- Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label PeriodCompletedNCT02611687Phase 3Results posted
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649CompletedNCT00690274Phase 2Results posted
- Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and AdolescentsActive, not recruitingNCT05953389Phase 2
- Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)CompletedNCT05849675Not applicable
- Pitolisant in Refractory Restless Legs SyndromeStatus unknownNCT05581576Phase 4
- A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic HypersomniaCompletedNCT05458128Phase 3
- A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSACompletedNCT05223166Phase 3
- Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant UsersCompletedNCT03152123Phase 1
- Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime SleepinessWithdrawnNCT02978651Phase 3
- Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male VolunteersCompletedNCT02929342Phase 1
- A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder TreatmentWithdrawnNCT02800083Phase 2
- Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSACompletedNCT02739568Phase 3
- Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)CompletedNCT01800045Phase 3
- Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)CompletedNCT01789398Phase 3
- Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.CompletedNCT01638403Phase 3
- Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)CompletedNCT01620554Phase 2
- Pharmacokinetics of BF2.649 in Renal ImpairmentCompletedNCT01619033Phase 1
- Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)CompletedNCT01399606Phase 3
- BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.CompletedNCT01072968Phase 3
- BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDSCompletedNCT01071876Phase 3
- Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With NarcolespyCompletedNCT01067235Phase 3
- Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in NarcolepsyCompletedNCT01067222Phase 3
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01066442Phase 3
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseCompletedNCT01036139Phase 3
- Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease PatientsCompletedNCT00642928Phase 2